You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Estimating the budget impact of orphan drugs in Sweden and France 2013–2020
|
|---|---|
| Published in |
Orphanet Journal of Rare Diseases, February 2014
|
| DOI | 10.1186/1750-1172-9-22 |
| Pubmed ID | |
| Authors |
Adam Hutchings, Carina Schey, Richard Dutton, Felix Achana, Karolina Antonov |
| Abstract |
The growth in expenditure on orphan medicinal products (OMP) across Europe has been identified as a concern. Estimates of future expenditure in Europe have suggested that OMPs could account for a significant proportion of total pharmaceutical expenditure in some countries, but few of these forecasts have been well validated. This analysis aims to establish a robust forecast of the future budget impact of OMPs on the healthcare systems in Sweden and France. |
X Demographics
The data shown below were collected from the profiles of 15 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 3 | 20% |
| Sweden | 3 | 20% |
| Luxembourg | 1 | 7% |
| Canada | 1 | 7% |
| Unknown | 7 | 47% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 13 | 87% |
| Scientists | 2 | 13% |
Mendeley readers
The data shown below were compiled from readership statistics for 75 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | 1% |
| Canada | 1 | 1% |
| Brazil | 1 | 1% |
| Unknown | 72 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 16 | 21% |
| Student > Master | 12 | 16% |
| Student > Ph. D. Student | 9 | 12% |
| Student > Bachelor | 7 | 9% |
| Other | 7 | 9% |
| Other | 12 | 16% |
| Unknown | 12 | 16% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 21 | 28% |
| Pharmacology, Toxicology and Pharmaceutical Science | 9 | 12% |
| Social Sciences | 5 | 7% |
| Agricultural and Biological Sciences | 4 | 5% |
| Business, Management and Accounting | 4 | 5% |
| Other | 15 | 20% |
| Unknown | 17 | 23% |
Attention Score in Context
This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 May 2019.
All research outputs
#3,185,854
of 25,374,647 outputs
Outputs from Orphanet Journal of Rare Diseases
#439
of 3,105 outputs
Outputs of similar age
#37,406
of 329,748 outputs
Outputs of similar age from Orphanet Journal of Rare Diseases
#5
of 43 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,105 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.2. This one has done well, scoring higher than 85% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 329,748 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 43 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 88% of its contemporaries.